ESC backs Abbott's bioabsorbable drug-eluting stent
This article was originally published in Clinica
Executive Summary
Further results from a study of Abbott's bioabsorbable drug-eluting stent (DES) technology have shown the device to be particularly efficacious at avoiding stent thrombosis, prompting a spokesperson for the European Society of Cardiology (ESC) to declare that the trial results had "really impressed" him.